Spring 2018 Teasers
Page 1 to 8 of 8 |
ARTIFICIAL INTELLIGENCE and biopharma R&D IT By The PRISME Forum
"R&D productivity remains an ongoing concern. Artificial Intelligence and the accompanying analytics are now so advanced that these tools promise to improve the traditional drug target selection and R&D process."

Read More

Bringing IO together: how an immunologist and oncologist collaborate By Dr Julia Schuler and Dr Louise Brackenbury
For many years, immunology and oncology operated as separate disciplines within drug discovery. However, recent advances in immuno-oncology (IO) have demonstrated what can be achieved when the two disciplines join forces in developing novel treatments for patients.

Read More

The Cancer Conundrum increasing clinical success By Lubna Hussain
Increasing clinical success by implementing improved methodologies in early phase drug discovery. Using primary cells and 3D culture models to enhance cancer drug discovery.

Read More

Driving strategic improvements in biologics drug discovery with scientific informatics By Dr Andrew LeBeau
Adoption of a scientific informatics system is essential to the success of every drug discovery organisation.

Read More

KINASES - old dogs and new tricks By Dr Gary Allenby
Application of new assay technologies to shed light on kinase drug discovery.

Read More

How high-throughput CRISPR is set to deliver knockout performance in drug discovery By Dr Paul Avery and Dr Richard Massey
CRISPR-Cas9 has rapidly transformed our ability to perform targeted gene editing. While the technique has received much interest for its potential in the field of gene therapy, advances in its high-throughput use mean it can now open up a wealth of opportunities in drug discovery too.

Read More

Natural born KILLERS - how natural killer cell therapy will transform immunotherapy By Dr Azusa Tanaka and Dr Michael Seiler
Regulatory approval of CAR-T cell therapies in 2017 placed the spotlight on immunotherapy approaches that use live cells to attack tumours – a major shift in oncology treatment.

Read More

Spring 2018 Teasers
Page 1 to 8 of 8 |